Computational and theoretical exploration for clinical suitability of Remdesivir drug to SARS-CoV-2
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference58 articles.
1. Atkins' Physical Chemistry;Atkins,2018
2. Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug- target interaction deep learning model;Beck;Comput. Struct. Biotechnol.J.,2020
3. Discovery Studio Visualizer;BIOVIA,2017
4. Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase;Brown;Antivir. Res.,2019
5. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: an evaluation of the evidence;Cao;Trav. Med. Infect. Dis.,2020
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design single-stranded DNA aptamer of cluster of differentiation 47 protein by stochastic tunnelling-basin hopping-discrete molecular dynamics method;Journal of Biomolecular Structure and Dynamics;2023-06-01
2. Prediction and validation of monoclonal antibodies separation in aqueous two-phase system using molecular dynamic simulation;Journal of Chromatography A;2023-04
3. The role of S477N mutation in the molecular behavior of SARS‐CoV‐2 spike protein: An in‐silico perspective;Journal of Cellular Biochemistry;2023-01-07
4. Structural requirements and interaction mechanisms of ACE inhibitory peptides: molecular simulation and thermodynamics studies on LAPYK and its modified peptides;Food Science and Human Wellness;2022-11
5. SARS‐CoV‐2 spike evolutionary behaviors; simulation of N501Y mutation outcomes in terms of immunogenicity and structural characteristic;Journal of Cellular Biochemistry;2021-11-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3